<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pediatr Nephrol</journal-id><journal-title>Pediatric Nephrology (Berlin, Germany)</journal-title><issn pub-type="ppub">0931-041X</issn><issn pub-type="epub">1432-198X</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18853201</article-id><article-id pub-id-type="pmc">2644746</article-id><article-id pub-id-type="publisher-id">1009</article-id><article-id pub-id-type="doi">10.1007/s00467-008-1009-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial Commentary</subject></subj-group></article-categories><title-group><article-title>Pathophysiological lessons from rare associations of immunological disorders</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ronco</surname><given-names>Pierre</given-names></name><address><email>pierre.ronco@tnn.aphp.fr</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Debiec</surname><given-names>Hanna</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Institut National de la Sant&#x000e9; et de la Recherche M&#x000e9;dicale (INSERM) Unit&#x000e9; Mixte de Recherche en Sant&#x000e9; (UMR) S 702, Paris, France </aff><aff id="Aff2"><label>2</label>Universit&#x000e9; Pierre et Marie Curie (UPMC) Paris Universitas, Paris, France </aff><aff id="Aff3"><label>3</label>Assistance Publique&#x02013;H&#x000f4;pitaux de Paris (AP-HP), H&#x000f4;pital Tenon, Service de N&#x000e9;phrologie et Dialyses, 4 rue de Chine, 75020 Paris, France </aff></contrib-group><pub-date pub-type="epub"><day>14</day><month>10</month><year>2008</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2009</year></pub-date><volume>24</volume><issue>1</issue><fpage>3</fpage><lpage>8</lpage><history><date date-type="received"><day>18</day><month>7</month><year>2008</year></date><date date-type="rev-recd"><day>18</day><month>8</month><year>2008</year></date><date date-type="accepted"><day>20</day><month>8</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; IPNA 2008</copyright-statement></permissions><abstract><p>Rare associations of immunological disorders can often tell more than mice and rats about the pathogenesis of immunologically mediated human kidney disease. Cases of glomerular disease with thyroiditis and Graves&#x02019; disease and of minimal change disease with lymphoepithelioma-like thymic carcinoma and lymphomatoid papulosis were recently reported in <italic>Pediatric Nephrology</italic>. These rare associations can contribute to the unraveling of the pathogenesis of membranous nephropathy (MN) and minimal change disease (MCD) and lead to the testing of novel research hypotheses. In MN, the target antigen may be thyroglobulin or another thyroid-released antigen that becomes planted in the glomerulus, but other scenarios can be envisaged, including epitope spreading, polyreactivity of pathogenic antibodies, and dysregulation of T regulatory cells, leading to the production of a variety of auto-antibodies with different specificities [immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX syndrome)]. The occurrence of MCD with hemopathies supports the role of T&#x000a0;cells in the pathogenesis of proteinuria, although the characteristics of those T&#x000a0;cells remain to be established and the glomerular permeability factor(s) identified.</p></abstract><kwd-group><title>Keywords</title><kwd>Membranous nephropathy</kwd><kwd>Minimal change disease</kwd><kwd>Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome</kwd><kwd>Epitope spreading</kwd><kwd>T regulatory cells</kwd><kwd>Glomerular permeability factor</kwd></kwd-group><custom-meta-wrap><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; IPNA 2009</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Membranous nephropathy (MN) and minimal change disease (MCD) rank among the most frequent glomerular diseases in adults and children, respectively. In the past years, significant advances have been made in the understanding of their pathophysiology, although there are still missing links.</p><p>Neutral endopeptidase, a zinc-dependent enzyme expressed on the surface of glomerular podocytes, has been identified as the first antigen responsible for MN in a small subset of patients with allo-immune antenatal glomerulopathy [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The mothers became immunized against neutral endopeptidase during pregnancy, because they were genetically deficient in this enzyme. The maternal antibodies were transferred to the fetus after the first trimester of pregnancy and reached their target antigen in the fetus glomeruli, where they induced a cascade of complement-mediated events leading to severe injury. Although neutral endopeptidase has not yet been found in immune deposits of adult patients with MN, the description of this rare allo-immune fetomaternal disease provided the proof of principle that podocyte antigens can serve as targets for in situ formation of nephritogenic immune complexes in the glomerular capillary wall. The next step will be to identify those antigens.</p><p>A possible link between abnormal T-cell response and MCD was postulated more than 30 years ago [<xref ref-type="bibr" rid="CR3">3</xref>]. Systemic infusion of supernatants of T&#x000a0;lymphocytes from patients with MCD relapse induced proteinuria in rats [<xref ref-type="bibr" rid="CR4">4</xref>]. Evidence of T-cell implication has accumulated during the past 10&#x000a0;years. This includes an expansion of CD4+ and CD8+ T-cell populations, high nuclear factor kappa B (NF&#x003ba;B) activation in CD4+ T&#x000a0;cells [<xref ref-type="bibr" rid="CR5">5</xref>], and upregulation in T&#x000a0;cells of RNA transcripts, which led to the identification of a new gene, the c-maf-inducing protein (<italic>c-mip</italic>) gene [<xref ref-type="bibr" rid="CR6">6</xref>]. The T-cell anomalies occur during relapse and disappear during remission. In addition, a role for CD34+ stem cells has also been pointed out [<xref ref-type="bibr" rid="CR7">7</xref>]. Cells expressing CD34 are normally found in the umbilical cord and bone marrow as hematopoietic cells and endothelial progenitor cells. The data suggest that the cells responsible for the pathogenesis of the nephrotic syndrome are more likely to be immature differentiating cells rather than mature peripheral T&#x000a0;cells. Although these findings point to a T&#x000a0;cell lineage disorder, the nature of the permeability factor(s) produced by T&#x000a0;cells or by T-cell activated &#x02018;inflammatory&#x02019; cells remains elusive.</p><p>Rare associations of immunological disorders may provide important clues to the pathogenesis of MN and MCD. In the past 6&#x000a0;months, four reports of such associations have appeared in <italic>Pediatric Nephrology</italic>. They include two cases of membranoproliferative and membranous glomerulonephritis (GN) associated with auto-immune thyroiditis and Graves&#x02019; disease, respectively, [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], and two cases of MCD associated with lymphomatoid papulosis [<xref ref-type="bibr" rid="CR10">10</xref>] and lymphoepithelioma-like thymic carcinoma [<xref ref-type="bibr" rid="CR11">11</xref>], respectively. We will build on those case reports and discuss how they can contribute to the understanding of renal diseases and to the opening of new research avenues.</p><sec id="Sec2"><title>The case of membranous/membranoproliferative glomerulonephritis and thyroiditis</title><p>Renal involvement in auto-immune thyroiditis is not uncommon, occurring in 10% to 30% of cases. Although several types of glomerulopathies, including MCD, immunoglobulin&#x000a0;A (IgA) nephropathy, rapidly progressive GN and membranoproliferative glomerulonephritis (MPGN), have been reported in patients with inflammatory thyroiditis, MN is the most frequent [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. MN can also occur in the course of Graves&#x02019; disease, where it may be associated with, or induced by, administration of 131-iodine (<sup>131</sup>I) [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. The pathogenesis of glomerular disease and the reason for the different patterns of glomerular injury in this setting are not well understood. The association of auto-immune thyroid disease with MN leads to discussion of the pathogenesis of immune deposits occurring in the glomerular capillary wall and to the proposal of new lines of investigation of the mechanisms whereby the release of thyroid antigens, particularly thyroglobulin and thyroperoxidase, may lead to an immune GN.</p><sec id="Sec3"><title>Are thyroglobulin-anti-thyroglobulin immune complexes the culprits?</title><p>Auto-immune thyroiditis or thyroid gland irradiation can induce the release in blood of thyroid antigens that trigger a specific immune response and the formation of immune complexes involving thyroid antigens [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Thyroglobulin and thyroperoxidase have been detected in subepithelial immune deposits [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR17">17</xref>], but there is no real proof that these antigens and the corresponding antibodies are pathogenic. Because of the increased permeability to proteins of the glomerular capillary wall, they may have been trapped passively in the glomerulus, as is the case for albumin. Although the thyroglobulin&#x02013;anti-thyroglobulin immune complexes (or other immune complexes involving thyroid antigens) can become deposited on the endothelial side of the glomerular basement membrane, it is unlikely that they can cross the basement membrane as a complex and give rise to subepithelial immune deposits. Because IgG4 is the main subclass deposited in MN [<xref ref-type="bibr" rid="CR18">18</xref>], the subclass of anti-thyroglobulin and anti-thyroperoxidase antibodies should be determined in the patients with thyroiditis-related GN. Indeed, IgG4 is characterized by low affinity for the antigen, so that thyroglobulin/thyroperoxidase&#x02013;IgG4 complexes may dissociate before crossing the basement membrane and then re-associate on the subepithelial side [<xref ref-type="bibr" rid="CR19">19</xref>], although there is no experimental evidence yet supporting this hypothesis. However, experiments performed by the group of G. Andres favor the concept of immune complex assembly and disassembly [<xref ref-type="bibr" rid="CR20">20</xref>]. Antibodies to angiotensin-converting enzyme expressed on glomerular endothelial cells induce patching of the antigen and shedding of the immune complexes at the surface of endothelial cells, followed by the formation of subepithelial immune deposits.</p><p>Perpetuation of auto-immune thyroiditis and production of secondary renal lesions were induced by periodic injection of aqueous preparations of altered thyroglobulin [<xref ref-type="bibr" rid="CR21">21</xref>]. Although thyroglobulin antigen may become planted in the glomerular capillary wall and, subsequently, serve as a target for nephritogenic anti-thyroglobulin antibodies, other scenarios can be envisaged, including epitope spreading, polyreactivity of pathogenic antibodies, and dysregulation of T regulatory cells, leading to the production of a variety of auto-antibodies with different specificities.</p></sec><sec id="Sec4"><title>Intra- and inter-molecular epitope spreading</title><p>The primary immune responses against self-antigens such as thyroglobulin tend to focus on one or few regions (called epitopes) of those antigens, thus using a very limited number of the available T-cell clones. This phenomenon is called immunodominance. If the immunodominant response fails to clear the target at first, the immune system will mount a more diversified, and possibly long-lasting, inflammatory response locally or systemically. This process of broadening the initially restricted immune response is called <italic>epitope spreading</italic> (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Spreading can occur within a single molecule (intramolecular), i.e. thyroglobulin, or among different molecules, possibly including antigens that are expressed in the glomerulus. Then, immune GN would be caused by a different subset of auto-antibodies than those that are initially raised against thyroglobulin or thyroperoxidase epitopes. It is believed that the spreading process involves altered antigen processing and presentation, as well as increased co-stimulation.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>B-cell epitope spreading. The primary immune response against the dominant initiating epitope (shown in <italic>red</italic>) may further extend to other epitopes within the same molecule (intramolecular epitope spreading) or among different molecules (intermolecular spreading). The initiating antigen is shown in <italic>blue</italic>. The secondary antigen is shown in <italic>green</italic></p></caption><graphic position="anchor" xlink:href="467_2008_1009_Fig1_HTML" id="MO1"/></fig></p><p>Epitope spreading has been demonstrated in experimental auto-immune thyroiditis [<xref ref-type="bibr" rid="CR22">22</xref>], Heymann nephritis, a reliable experimental model of MN [<xref ref-type="bibr" rid="CR23">23</xref>], and in experimental auto-immune GN induced in rats by a T-cell epitope of Goodpasture&#x02019;s antigen [<xref ref-type="bibr" rid="CR24">24</xref>]. It has also been identified in systemic lupus erythematosus, where triggering peptide sequences have been characterized [<xref ref-type="bibr" rid="CR25">25</xref>]. Epitope spreading has been demonstrated during experimental immunization with an immunogenic thyroglobulin peptide [<xref ref-type="bibr" rid="CR26">26</xref>], but, to our knowledge, it has not been investigated in patients with auto-immune thyroiditis. Yet this phenomenon may be relevant to pathogenesis of disease, since, in Heymann nephritis, the onset of proteinuria correlates with intramolecular epitope spreading [<xref ref-type="bibr" rid="CR23">23</xref>].</p></sec><sec id="Sec5"><title>Polyreactivity of pathogenic antibodies</title><p>Most studies of auto-antibody-mediated tissue damage have focused on the role of anti-double-stranded DNA antibodies in patients with lupus nephritis [<xref ref-type="bibr" rid="CR27">27</xref>]. It has been proposed that anti-double-stranded DNA, anti-nucleosome antibodies, or both, cross-react with proteins in the kidney; thus, they may have a direct pathogenic effect on renal cells. This is an example of polyreactivity, whereby the same antibody can bind to antigens with different structures because they have similar surface shapes or areas of similar charges (so-called shared epitopes or mimotopes) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Among possible target antigens in the kidney, attention is currently focused on &#x003b1;-actinin. This protein that cross-links actin (a component of the cytoskeleton) is critical for maintaining the function of renal podocytes. Two studies have shown that mouse monoclonal anti-DNA antibodies that cross-reacted with &#x003b1;-actinin were pathogenic, whereas monoclonal antibodies that did not cross-react with &#x003b1;-actinin were not pathogenic [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Anti-&#x003b1;-actinin antibodies are non-specific for lupus. Whether anti-&#x003b1;-actinin antibodies can cross-react with thyroglobulin or other thyroid antigens remains to be established.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Polyreactivity of antibody. The same antibody can bind to different molecules shown in <italic>blue</italic> and <italic>green</italic>, respectively, because they have similar surface shapes or areas of similar charge. The epitope is shown as a <italic>blue star</italic>. In polyreactive antibodies, the antigen-binding pocket is more flexible</p></caption><graphic position="anchor" xlink:href="467_2008_1009_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec6"><title>T-cell dysregulation and immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome</title><p>Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a severe auto-immune syndrome which highlights the importance of the reporting of rare associations and their relevance to basic science.</p><p>Usually, the onset of the disease is in early infancy, and the course is rapidly fatal. The enteropathy manifests itself as a severe refractory and life-threatening diarrhea associated with villous atrophy. Other auto-immune manifestations include polyendocrinopathies such as type 1 diabetes, hypothyroidism, hemolytic anemia, and thrombocytopenia, usually with the presence of auto-antibodies. In addition, eczema, typically correlated with elevated titers of IgE in the serum, has also been reported. IPEX is caused by mutations in the <italic>forkhead box protein P3 (FOXP3)</italic> gene [<xref ref-type="bibr" rid="CR30">30</xref>], which induce a dysfunction in CD4+ CD25<sup>high</sup> T regulatory (T reg) cells and in effector T&#x000a0;cells [<xref ref-type="bibr" rid="CR31">31</xref>]. This rare entity thus shows that multiple auto-immune manifestations, including hypothyroidism, can be caused by T reg defects.</p><p>Very interestingly, the first case of kidney involvement in IPEX syndrome was described in the early 1990s by Ren&#x000e9;e Habib&#x02019;s group [<xref ref-type="bibr" rid="CR32">32</xref>], who reported a case of MN associated with severe auto-immune enteropathy (AIE) with anti-enterocyte antibodies, anti-tubular basement membrane antibodies, and anti-brush-border antibodies. Target antigens include proteins with molecular weight (MW) of 75&#x000a0;kDa, 58&#x000a0;kDa and 55&#x000a0;kDa, with the anti-AIE-75 antibodies being specific for auto-immune enteropathies with renal involvement [<xref ref-type="bibr" rid="CR33">33</xref>]. Whether the antigen is also expressed on the podocyte surface remains to be established.</p><p>IPEX is an example of T-cell dysregulation associated with MN. The disease is rare, but retrospective data suggest that its actual frequency may be underestimated. The association of MN with unusual auto-immune manifestations in male patients must trigger investigations in the patient&#x02019;s family and lead to the consideration of T-cell dysregulation and <italic>FOXP3</italic> mutations as a potential cause of the disease. We suggest that IPEX and related syndromes may be the cause of childhood MN with anti-tubular basement membrane and/or anti-brush-border antibodies.</p></sec></sec><sec id="Sec7"><title>The case of nephrotic syndrome (minimal change disease) and hemopathies</title><p>Because MCD is considered to be a consequence of immune cell dysfunction that may lead to release of a glomerular permeability factor, particular attention has been paid to the association of MCD with hemopathies, particularly those of lymphoid origin or involving lymphoid cells. The best example of MCD associated with hemopathy is Hodgkin&#x02019;s lymphoma (HL). Although this association is rare, representing only 0.4% of cases in the two largest studies of 1,700 Hodgkin&#x02019;s disease patients, a close relationship between the courses of HL and MCD has been reported in patients who suffer from both diseases; particularly, remission of MCD occurs after successful treatment of HL, suggesting that MCD is a paraneoplastic syndrome in the context of HL [<xref ref-type="bibr" rid="CR34">34</xref>]. Hodgkin Reed&#x02013;Sternberg cells seem to derive from germinal center B&#x000a0;cells, and molecular studies suggest that, in rare cases, they may derive from T cells [<xref ref-type="bibr" rid="CR35">35</xref>]. However, in a recent retrospective French study of 21 cases [<xref ref-type="bibr" rid="CR36">36</xref>], Audard et al. failed to demonstrate expression of T-cell markers. Nonetheless, in agreement with the hypothesis of T-cell impairment, many similarities concerning T-cell function during MCD and Hodgkin&#x02019;s lymphoma have been documented [<xref ref-type="bibr" rid="CR36">36</xref>]. Both diseases are associated with an expansion of T cells polarized towards a Th2 phenotype with Th2 cytokines, particularly interleukin-13 (IL-13), being involved; consistent NF&#x003ba;-B overexpression in Reed&#x02013;Sternberg cells and in peripheral mononuclear cells including T&#x000a0;cells during MCD relapse has been documented. The fact that MCD-related nephrotic syndrome disappears when lymphoma is cured strongly supports the existence of a permeability factor which may be secreted by the Hodgkin&#x02019;s cells or by the surrounding inflammatory cells.</p><p>Recently, two reports in <italic>Pediatric Nephrology</italic> on the association of MCD with lymphoepithelioma-like thymic carcinoma [<xref ref-type="bibr" rid="CR11">11</xref>] and lymphomatoid papulosis [<xref ref-type="bibr" rid="CR10">10</xref>] further support the concept of a permeability factor secreted by T&#x000a0;cells. Lymphomatoid papulosis of the skin is considered to be a CD30+ cutaneous lymphoma of uncertain malignant potential. The patient presented a series of remissions and relapses synchronous with the nephrotic syndrome. The etiology of the disease is unknown, but it is relevant that lymphomatoid papulosis can be concomitant with, or followed by, other lymphomas, such as mycosis fungoides and Hodgkin&#x02019;s lymphoma. This raises the question of a common origin of the diseases, because, in some cases, the same neoplastic T-cell clone has been identified in lesions of lymphomatoid papulosis and in the other developed malignancy [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p>The largest series of patients with renal involvement associated with thymic pathology was published by Karras et al. [<xref ref-type="bibr" rid="CR38">38</xref>]. The case reported by Kili&#x0015b;-Pstrusi&#x00144;ska et al. [<xref ref-type="bibr" rid="CR11">11</xref>] is the first one of MCD associated with lymphoepithelioma-like thymic carcinoma in a pediatric patient. Thymomas have been associated with different auto-immune diseases [<xref ref-type="bibr" rid="CR38">38</xref>] most likely due to the induction of auto-reactive T-cell clones. As in the diseases mentioned above, the dysregulation of T-cell activity and/or increased production of several lymphokines by activated T lymphocytes may alter renal glomerular permeability.</p><p>These rare associations may provide useful cell tools and sera to further investigate the pathophysiology of MCD, which remains largely elusive. First, the screening of genes upregulated in the T&#x000a0;cells of patients with MCD relapse has led to the identification of c-mip in the T cells [<xref ref-type="bibr" rid="CR5">5</xref>]. Analysis of c-mip expression in Hodgkin&#x02019;s Reed&#x02013;Sternberg cells, in abnormal thymic cells, and in lymphomatoid papulosis cells, would be of great interest. One important question that remains to be solved relates to the peculiar characteristics of Hodgkin&#x02019;s cells associated with MCD: c-mip expression in those cells might help identify patients with Hodgkin&#x02019;s lymphoma and a risk for MCD. In addition, the finding of c-mip overexpression in lymphoma cells in the patients who develop MCD would further support a role for c-mip in the pathophysiology of MCD. Second, immortalization of the involved lymphoma cells could provide valuable material for isolation of glomerular permeability factor(s).</p><p>In conclusion, much has been learned in the past few years from the careful analysis of single observations of well-phenotyped patients. However, the editorial policy of a number of medical journals tends to exclude isolated reports of single cases. For lack of time due to a dramatic shortage or reduction in the number of nephrologists in many countries [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>], and because of the epidemics of chronic kidney disease, little attention is being paid to unusual presentations of clinical cases or to rare associations of diseases. This is a threat to future progress in medicine. Rare human cases can tell more than extensive studies in mice and rats.</p></sec></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Debiec</surname><given-names>H</given-names></name><name><surname>Guigonis</surname><given-names>V</given-names></name><name><surname>Mougenot</surname><given-names>B</given-names></name><name><surname>Decobert</surname><given-names>F</given-names></name><name><surname>Haymann</surname><given-names>JP</given-names></name><name><surname>Bensman</surname><given-names>A</given-names></name><name><surname>Deschenes</surname><given-names>G</given-names></name><name><surname>Ronco</surname><given-names>P</given-names></name></person-group><article-title>Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><fpage>2053</fpage><lpage>2060</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa012895</pub-id></citation><citation citation-type="display-unstructured">Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschenes G, Ronco P (2002) Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346:2053&#x02013;2060 <pub-id pub-id-type="pmid">12087141</pub-id></citation></ref><ref id="CR2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Debiec</surname><given-names>H</given-names></name><name><surname>Nauta</surname><given-names>J</given-names></name><name><surname>Coulet</surname><given-names>F</given-names></name><name><surname>Burg</surname><given-names>M</given-names></name><name><surname>Guigonis</surname><given-names>V</given-names></name><name><surname>Schumans</surname><given-names>T</given-names></name><name><surname>Heer</surname><given-names>E</given-names></name><name><surname>Soubrier</surname><given-names>F</given-names></name><name><surname>Janssen</surname><given-names>F</given-names></name><name><surname>Ronco</surname><given-names>P</given-names></name></person-group><article-title>Role of truncating mutations in MME gene in feto-maternal allo-immunization and neonatal glomerulopathies</article-title><source>Lancet</source><year>2004</year><volume>364</volume><fpage>1252</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(04)17142-0</pub-id></citation><citation citation-type="display-unstructured">Debiec H, Nauta J, Coulet F, van der Burg M, Guigonis V, Schumans T, de Heer E, Soubrier F, Janssen F, Ronco P (2004) Role of truncating mutations in MME gene in feto-maternal allo-immunization and neonatal glomerulopathies. Lancet 364:1252&#x02013;1259 <pub-id pub-id-type="pmid">15464186</pub-id></citation></ref><ref id="CR3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shalhoub</surname><given-names>RJ</given-names></name></person-group><article-title>Pathogenesis of lipoid nephrosis: a disorder of T-cell function</article-title><source>Lancet</source><year>1974</year><volume>2</volume><fpage>556</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(74)91880-7</pub-id></citation><citation citation-type="display-unstructured">Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2:556&#x02013;560 <pub-id pub-id-type="pmid">4140273</pub-id></citation></ref><ref id="CR4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lagrue</surname><given-names>G</given-names></name><name><surname>Xheneumont</surname><given-names>S</given-names></name><name><surname>Branellec</surname><given-names>A</given-names></name><name><surname>Hirbec</surname><given-names>G</given-names></name><name><surname>Weil</surname><given-names>B</given-names></name></person-group><article-title>A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome</article-title><source>Biomedicine</source><year>1975</year><volume>23</volume><fpage>37</fpage><lpage>40</lpage></citation><citation citation-type="display-unstructured">Lagrue G, Xheneumont S, Branellec A, Hirbec G, Weil B (1975) A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome. Biomedicine 23:37&#x02013;40 <pub-id pub-id-type="pmid">1174637</pub-id></citation></ref><ref id="CR5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sahali</surname><given-names>D</given-names></name><name><surname>Pawlak</surname><given-names>A</given-names></name><name><surname>Gouvello</surname><given-names>S</given-names></name><name><surname>Lang</surname><given-names>P</given-names></name><name><surname>Valanciut&#x000e9;</surname><given-names>A</given-names></name><name><surname>Remy</surname><given-names>P</given-names></name><name><surname>Loirat</surname><given-names>C</given-names></name><name><surname>Niaudet</surname><given-names>P</given-names></name><name><surname>Bensman</surname><given-names>A</given-names></name><name><surname>Guellaen</surname><given-names>G</given-names></name></person-group><article-title>Transcriptional and post-transcriptional alterations of I&#x003ba;B&#x003b1; in active minimal-change nephrotic syndrome</article-title><source>J Am Soc Nephrol</source><year>2001</year><volume>12</volume><fpage>1648</fpage><lpage>1658</lpage></citation><citation citation-type="display-unstructured">Sahali D, Pawlak A, Le Gouvello S, Lang P, Valanciut&#x000e9; A, Remy P, Loirat C, Niaudet P, Bensman A, Guellaen G (2001) Transcriptional and post-transcriptional alterations of I&#x003ba;B&#x003b1; in active minimal-change nephrotic syndrome. J Am Soc Nephrol 12:1648&#x02013;1658 <pub-id pub-id-type="pmid">11461937</pub-id></citation></ref><ref id="CR6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grimbert</surname><given-names>P</given-names></name><name><surname>Valanciute</surname><given-names>A</given-names></name><name><surname>Audard</surname><given-names>V</given-names></name><name><surname>Pawlak</surname><given-names>A</given-names></name><name><surname>gouvelo</surname><given-names>S</given-names></name><name><surname>Lang</surname><given-names>P</given-names></name><name><surname>Niaudet</surname><given-names>P</given-names></name><name><surname>Bensman</surname><given-names>A</given-names></name><name><surname>Guella&#x000eb;n</surname><given-names>G</given-names></name><name><surname>Sahali</surname><given-names>D</given-names></name></person-group><article-title>Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization</article-title><source>J Exp Med</source><year>2003</year><volume>198</volume><fpage>797</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1084/jem.20030566</pub-id></citation><citation citation-type="display-unstructured">Grimbert P, Valanciute A, Audard V, Pawlak A, Le gouvelo S, Lang P, Niaudet P, Bensman A, Guella&#x000eb;n G, Sahali D (2003) Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization. J Exp Med 198:797&#x02013;807 <pub-id pub-id-type="pmid">12939343</pub-id></citation></ref><ref id="CR7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sellier-Leclerc</surname><given-names>AL</given-names></name><name><surname>Duval</surname><given-names>A</given-names></name><name><surname>Riveron</surname><given-names>S</given-names></name><name><surname>Macher</surname><given-names>MA</given-names></name><name><surname>Deschenes</surname><given-names>G</given-names></name><name><surname>Loirat</surname><given-names>C</given-names></name><name><surname>Verpont</surname><given-names>MC</given-names></name><name><surname>Peuchmaur</surname><given-names>M</given-names></name><name><surname>Ronco</surname><given-names>P</given-names></name><name><surname>Monteiro</surname><given-names>RC</given-names></name><name><surname>Haddad</surname><given-names>E</given-names></name></person-group><article-title>A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells</article-title><source>J Am Soc Nephrol</source><year>2007</year><volume>18</volume><fpage>2732</fpage><lpage>2739</lpage><pub-id pub-id-type="doi">10.1681/ASN.2006121346</pub-id></citation><citation citation-type="display-unstructured">Sellier-Leclerc AL, Duval A, Riveron S, Macher MA, Deschenes G, Loirat C, Verpont MC, Peuchmaur M, Ronco P, Monteiro RC, Haddad E (2007) A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J Am Soc Nephrol 18:2732&#x02013;2739 <pub-id pub-id-type="pmid">17855645</pub-id></citation></ref><ref id="CR8"><label>8.</label><citation citation-type="other">Gurkan S, Dikman S, Saland MJ (2008) A case of autoimmune thyroiditis and membranoproliferative glomerulonephritis. Pediatr Nephrol doi:10.1007/s00467-007-0668-y</citation></ref><ref id="CR9"><label>9.</label><citation citation-type="other">Shima Y, Nakanishi K, Togawa H, Obana M, Sako M, Miyawaki M, Nozu K, Iijima K, Yoshikawa N (2008) Membranous nephropathy associated with thyroid-peroxidase antigen. Pediatr Nephrol doi:10.1007/s00467-008-0973-0</citation></ref><ref id="CR10"><label>10.</label><citation citation-type="other">Ghiggeri GM, Bleid D, Garaventa A, Coccia C, Gambini C, Caridi G, Perfumo F (2008) Lymphomatoid papulosis associated with nephrotic syndrome. An occurrence of uncertain origin. Pediatr Nephrol doi:10.1007/s00467-007-0667-z</citation></ref><ref id="CR11"><label>11.</label><citation citation-type="other">Kili&#x0015b;-Pstrusi&#x00144;ska K, Medy&#x00144;ska A, Zwoli&#x00144;ska D, Dobaczewski G (2008) Lymphoepithelioma-like thymic carcinoma in a 16-year-old boy with nephrotic syndrome-a case report. Pediatr Nephrol 23:1001&#x02013;1003 doi:10.1007/s00467-007-0666-0</citation></ref><ref id="CR12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Illies</surname><given-names>F</given-names></name><name><surname>Wingen</surname><given-names>AM</given-names></name><name><surname>Bald</surname><given-names>M</given-names></name><name><surname>Hoyer</surname><given-names>PF</given-names></name></person-group><article-title>Autoimmune thyroiditis in association with membranous nephropathy</article-title><source>J Pediatr Endocrinol Metab</source><year>2004</year><volume>17</volume><fpage>99</fpage><lpage>104</lpage></citation><citation citation-type="display-unstructured">Illies F, Wingen AM, Bald M, Hoyer PF (2004) Autoimmune thyroiditis in association with membranous nephropathy. J Pediatr Endocrinol Metab 17:99&#x02013;104 <pub-id pub-id-type="pmid">14960028</pub-id></citation></ref><ref id="CR13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grcevska</surname><given-names>L</given-names></name><name><surname>Polenakovic</surname><given-names>M</given-names></name><name><surname>Petrusevska</surname><given-names>G</given-names></name></person-group><article-title>Membranous nephropathy associated with thyroid disorders</article-title><source>Nephron</source><year>2000</year><volume>86</volume><fpage>534</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1159/000045857</pub-id></citation><citation citation-type="display-unstructured">Grcevska L, Polenakovic M, Petrusevska G (2000) Membranous nephropathy associated with thyroid disorders. Nephron 86:534&#x02013;535 <pub-id pub-id-type="pmid">11124617</pub-id></citation></ref><ref id="CR14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horikoshi</surname><given-names>T</given-names></name><name><surname>Tamura</surname><given-names>J</given-names></name><name><surname>Kaneko</surname><given-names>Y</given-names></name><name><surname>Maezawa</surname><given-names>A</given-names></name><name><surname>Kanai</surname><given-names>H</given-names></name><name><surname>Kaji</surname><given-names>T</given-names></name><name><surname>Matsushima</surname><given-names>T</given-names></name><name><surname>Sawamura</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>H</given-names></name><name><surname>Yano</surname><given-names>S</given-names></name><name><surname>Kubota</surname><given-names>K</given-names></name><name><surname>Naruse</surname><given-names>T</given-names></name></person-group><article-title>Membranous nephropathy associated with chronic thyroiditis</article-title><source>Nephron</source><year>1993</year><volume>63</volume><fpage>246</fpage></citation><citation citation-type="display-unstructured">Horikoshi T, Tamura J, Kaneko Y, Maezawa A, Kanai H, Kaji T, Matsushima T, Sawamura M, Murakami H, Yano S, Kubota K, Naruse T (1993) Membranous nephropathy associated with chronic thyroiditis. Nephron 63:246 <pub-id pub-id-type="pmid">8450926</pub-id></citation></ref><ref id="CR15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ploth</surname><given-names>DW</given-names></name><name><surname>Fitz</surname><given-names>A</given-names></name><name><surname>Schnetzler</surname><given-names>D</given-names></name><name><surname>Seidenfeld</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>CB</given-names></name></person-group><article-title>Thyroglobulin-anti-thyroglobulin immune complex glomerulonephritis complicating radioiodine therapy</article-title><source>Clin Immunol Immunopathol</source><year>1978</year><volume>9</volume><fpage>327</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/0090-1229(78)90104-6</pub-id></citation><citation citation-type="display-unstructured">Ploth DW, Fitz A, Schnetzler D, Seidenfeld J, Wilson CB (1978) Thyroglobulin-anti-thyroglobulin immune complex glomerulonephritis complicating radioiodine therapy. Clin Immunol Immunopathol 9:327&#x02013;334 <pub-id pub-id-type="pmid">342161</pub-id></citation></ref><ref id="CR16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>BA</given-names></name><name><surname>Fenves</surname><given-names>AZ</given-names></name><name><surname>Breslau</surname><given-names>NA</given-names></name></person-group><article-title>Membranous glomerulonephritis associated with Graves&#x02019; disease</article-title><source>Am J Kidney Dis</source><year>1999</year><volume>33</volume><fpage>369</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/S0272-6386(99)70314-8</pub-id></citation><citation citation-type="display-unstructured">Becker BA, Fenves AZ, Breslau NA (1999) Membranous glomerulonephritis associated with Graves&#x02019; disease. Am J Kidney Dis 33:369&#x02013;373 <pub-id pub-id-type="pmid">10023652</pub-id></citation></ref><ref id="CR17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname><given-names>SC</given-names></name><name><surname>Buckingham</surname><given-names>B</given-names></name><name><surname>Sakai</surname><given-names>R</given-names></name><name><surname>Olson</surname><given-names>D</given-names></name></person-group><article-title>Studies of immune-complex glomerulonephritis mediated by human thyroglobulin</article-title><source>N Engl J Med</source><year>1981</year><volume>304</volume><fpage>1212</fpage><lpage>1215</lpage></citation><citation citation-type="display-unstructured">Jordan SC, Buckingham B, Sakai R, Olson D (1981) Studies of immune-complex glomerulonephritis mediated by human thyroglobulin. N Engl J Med 304:1212&#x02013;1215 <pub-id pub-id-type="pmid">7012624</pub-id></citation></ref><ref id="CR18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ronco</surname><given-names>P</given-names></name><name><surname>Debiec</surname><given-names>H</given-names></name></person-group><article-title>Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men</article-title><source>Semin Immunopathol</source><year>2007</year><volume>29</volume><fpage>445</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1007/s00281-007-0091-2</pub-id></citation><citation citation-type="display-unstructured">Ronco P, Debiec H (2007) Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men. Semin Immunopathol 29:445&#x02013;458 <pub-id pub-id-type="pmid">17899086</pub-id></citation></ref><ref id="CR19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>DB</given-names></name></person-group><article-title>Membranous nephropathy: an IgG4-mediated disease</article-title><source>Lancet</source><year>1998</year><volume>351</volume><fpage>670</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(97)04122-6</pub-id></citation><citation citation-type="display-unstructured">Oliveira DB (1998) Membranous nephropathy: an IgG4-mediated disease. Lancet 351:670&#x02013;671 <pub-id pub-id-type="pmid">9500350</pub-id></citation></ref><ref id="CR20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>S</given-names></name><name><surname>Fukatsu</surname><given-names>A</given-names></name><name><surname>Taub</surname><given-names>ML</given-names></name><name><surname>Caldwell</surname><given-names>PR</given-names></name><name><surname>Brentjens</surname><given-names>JR</given-names></name><name><surname>Andres</surname><given-names>G</given-names></name></person-group><article-title>Glomerulonephritis induced in the rabbit by antiendothelial antibodies</article-title><source>J Clin Invest</source><year>1987</year><volume>79</volume><fpage>1798</fpage><lpage>1811</lpage><pub-id pub-id-type="doi">10.1172/JCI113021</pub-id></citation><citation citation-type="display-unstructured">Matsuo S, Fukatsu A, Taub ML, Caldwell PR, Brentjens JR, Andres G (1987) Glomerulonephritis induced in the rabbit by antiendothelial antibodies. J Clin Invest 79:1798&#x02013;1811 <pub-id pub-id-type="pmid">3034982</pub-id></citation></ref><ref id="CR21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weigle</surname><given-names>WO</given-names></name><name><surname>Nakamura</surname><given-names>RM</given-names></name></person-group><article-title>Perpetuation of autoimmune thyroiditis and production of secondary renal lesions following periodic injections of aqueous preparations of altered thyroglobulin</article-title><source>Clin Exp Immunol</source><year>1969</year><volume>4</volume><fpage>645</fpage><lpage>657</lpage></citation><citation citation-type="display-unstructured">Weigle WO, Nakamura RM (1969) Perpetuation of autoimmune thyroiditis and production of secondary renal lesions following periodic injections of aqueous preparations of altered thyroglobulin. Clin Exp Immunol 4:645&#x02013;657 <pub-id pub-id-type="pmid">4891244</pub-id></citation></ref><ref id="CR22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>YD</given-names></name><name><surname>Carayanniotis</surname><given-names>G</given-names></name><name><surname>Sercarz</surname><given-names>E</given-names></name></person-group><article-title>Antigen processing by autoreactive B cells promotes determinant spreading</article-title><source>Cell Mol Immunol</source><year>2005</year><volume>2</volume><fpage>169</fpage><lpage>175</lpage></citation><citation citation-type="display-unstructured">Dai YD, Carayanniotis G, Sercarz E (2005) Antigen processing by autoreactive B cells promotes determinant spreading. Cell Mol Immunol 2:169&#x02013;175 <pub-id pub-id-type="pmid">16212883</pub-id></citation></ref><ref id="CR23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>P</given-names></name><name><surname>Tramontano</surname><given-names>A</given-names></name><name><surname>Makker</surname><given-names>SP</given-names></name></person-group><article-title>Intramolecular spreading in Heymann nephritis</article-title><source>J Am Soc Nephrol</source><year>2007</year><volume>18</volume><fpage>3060</fpage><lpage>3066</lpage><pub-id pub-id-type="doi">10.1681/ASN.2007030342</pub-id></citation><citation citation-type="display-unstructured">Shah P, Tramontano A, Makker SP (2007) Intramolecular spreading in Heymann nephritis. J Am Soc Nephrol 18:3060&#x02013;3066 <pub-id pub-id-type="pmid">18003776</pub-id></citation></ref><ref id="CR24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolton</surname><given-names>WK</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Hellmark</surname><given-names>T</given-names></name><name><surname>Wieslander</surname><given-names>J</given-names></name><name><surname>Fox</surname><given-names>JW</given-names></name></person-group><article-title>Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture&#x02019;s antigen</article-title><source>J Am Soc Nephrol</source><year>2005</year><volume>16</volume><fpage>2657</fpage><lpage>2666</lpage><pub-id pub-id-type="doi">10.1681/ASN.2004100823</pub-id></citation><citation citation-type="display-unstructured">Bolton WK, Chen L, Hellmark T, Wieslander J, Fox JW (2005) Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture&#x02019;s antigen. J Am Soc Nephrol 16:2657&#x02013;2666 <pub-id pub-id-type="pmid">16049074</pub-id></citation></ref><ref id="CR25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monneaux</surname><given-names>F</given-names></name><name><surname>Muller</surname><given-names>S</given-names></name></person-group><article-title>Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences</article-title><source>Arthritis Rheum</source><year>2002</year><volume>46</volume><fpage>1430</fpage><lpage>1438</lpage><pub-id pub-id-type="doi">10.1002/art.10263</pub-id></citation><citation citation-type="display-unstructured">Monneaux F, Muller S (2002) Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences. Arthritis Rheum 46:1430&#x02013;1438 <pub-id pub-id-type="pmid">12115171</pub-id></citation></ref><ref id="CR26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thrasyvoulides</surname><given-names>A</given-names></name><name><surname>Lymberi</surname><given-names>P</given-names></name></person-group><article-title>Evidence for intramolecular B-cell epitope spreading during experimental immunization with an immunogenic thyroglobulin peptide</article-title><source>Clin Exp Immunol</source><year>2003</year><volume>132</volume><fpage>401</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2249.2003.02162.x</pub-id></citation><citation citation-type="display-unstructured">Thrasyvoulides A, Lymberi P (2003) Evidence for intramolecular B-cell epitope spreading during experimental immunization with an immunogenic thyroglobulin peptide. Clin Exp Immunol 132:401&#x02013;407 <pub-id pub-id-type="pmid">12780685</pub-id></citation></ref><ref id="CR27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Isenberg</surname><given-names>DA</given-names></name></person-group><article-title>Systemic lupus erythematosus</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>929</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1056/NEJMra071297</pub-id></citation><citation citation-type="display-unstructured">Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358:929&#x02013;939 <pub-id pub-id-type="pmid">18305268</pub-id></citation></ref><ref id="CR28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mostoslavsky</surname><given-names>G</given-names></name><name><surname>Fischel</surname><given-names>R</given-names></name><name><surname>Yachimovich</surname><given-names>N</given-names></name><name><surname>Yarkoni</surname><given-names>Y</given-names></name><name><surname>Rosenmann</surname><given-names>E</given-names></name><name><surname>Monestier</surname><given-names>M</given-names></name><name><surname>Baniyash</surname><given-names>M</given-names></name><name><surname>Eilat</surname><given-names>D</given-names></name></person-group><article-title>Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry</article-title><source>Eur J Immunol</source><year>2001</year><volume>31</volume><fpage>1221</fpage><lpage>1227</lpage><pub-id pub-id-type="doi">10.1002/1521-4141(200104)31:4&#x0003c;1221::AID-IMMU1221&#x0003e;3.0.CO;2-P</pub-id></citation><citation citation-type="display-unstructured">Mostoslavsky G, Fischel R, Yachimovich N, Yarkoni Y, Rosenmann E, Monestier M, Baniyash M, Eilat D (2001) Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 31:1221&#x02013;1227 <pub-id pub-id-type="pmid">11298348</pub-id></citation></ref><ref id="CR29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deocharan</surname><given-names>B</given-names></name><name><surname>Qing</surname><given-names>X</given-names></name><name><surname>Lichauco</surname><given-names>J</given-names></name><name><surname>Putterman</surname><given-names>C</given-names></name></person-group><article-title>Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>3072</fpage><lpage>3078</lpage></citation><citation citation-type="display-unstructured">Deocharan B, Qing X, Lichauco J, Putterman C (2002) Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 168:3072&#x02013;3078 <pub-id pub-id-type="pmid">11884481</pub-id></citation></ref><ref id="CR30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wildin</surname><given-names>RS</given-names></name><name><surname>Ramsdell</surname><given-names>F</given-names></name><name><surname>Peake</surname><given-names>J</given-names></name><name><surname>Faravelli</surname><given-names>F</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Buist</surname><given-names>N</given-names></name><name><surname>Levy-Lahad</surname><given-names>E</given-names></name><name><surname>Mazzella</surname><given-names>M</given-names></name><name><surname>Goulet</surname><given-names>O</given-names></name><name><surname>Perroni</surname><given-names>L</given-names></name><name><surname>Bricarelli</surname><given-names>FD</given-names></name><name><surname>Byrne</surname><given-names>G</given-names></name><name><surname>McEuen</surname><given-names>M</given-names></name><name><surname>Proll</surname><given-names>S</given-names></name><name><surname>Appleby</surname><given-names>M</given-names></name><name><surname>Brunkow</surname><given-names>ME</given-names></name></person-group><article-title>X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy</article-title><source>Nat Genet</source><year>2001</year><volume>27</volume><fpage>18</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/83707</pub-id></citation><citation citation-type="display-unstructured">Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27:18&#x02013;20 <pub-id pub-id-type="pmid">11137992</pub-id></citation></ref><ref id="CR31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bacchetta</surname><given-names>R</given-names></name><name><surname>Passerini</surname><given-names>L</given-names></name><name><surname>Gambineri</surname><given-names>E</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name><name><surname>Allan</surname><given-names>SE</given-names></name><name><surname>Perroni</surname><given-names>L</given-names></name><name><surname>Dagna-Bricarelli</surname><given-names>F</given-names></name><name><surname>Sartirana</surname><given-names>C</given-names></name><name><surname>Matthes-Martin</surname><given-names>S</given-names></name><name><surname>Lawitschka</surname><given-names>A</given-names></name><name><surname>Azzari</surname><given-names>C</given-names></name><name><surname>Ziegler</surname><given-names>SF</given-names></name><name><surname>Levings</surname><given-names>MK</given-names></name><name><surname>Roncarolo</surname><given-names>MG</given-names></name></person-group><article-title>Defective regulatory and effector T cell functions in patients with FOXP3 mutations</article-title><source>J Clin Invest</source><year>2006</year><volume>116</volume><fpage>1713</fpage><lpage>1722</lpage><pub-id pub-id-type="doi">10.1172/JCI25112</pub-id></citation><citation citation-type="display-unstructured">Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, Dagna-Bricarelli F, Sartirana C, Matthes-Martin S, Lawitschka A, Azzari C, Ziegler SF, Levings MK, Roncarolo MG (2006) Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 116:1713&#x02013;1722 <pub-id pub-id-type="pmid">16741580</pub-id></citation></ref><ref id="CR32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>R</given-names></name><name><surname>Beziau</surname><given-names>A</given-names></name><name><surname>Goulet</surname><given-names>O</given-names></name><name><surname>Blanche</surname><given-names>S</given-names></name><name><surname>Niaudet</surname><given-names>P</given-names></name></person-group><article-title>Renal involvement in autoimmune enteropathies</article-title><source>Ann Pediatr (Paris)</source><year>1993</year><volume>40</volume><fpage>103</fpage><lpage>107</lpage></citation><citation citation-type="display-unstructured">Habib R, Beziau A, Goulet O, Blanche S, Niaudet P (1993) Renal involvement in autoimmune enteropathies. Ann Pediatr (Paris) 40:103&#x02013;107 <pub-id pub-id-type="pmid">8457129</pub-id></citation></ref><ref id="CR33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>I</given-names></name><name><surname>Imamura</surname><given-names>K</given-names></name><name><surname>Kubota</surname><given-names>M</given-names></name><name><surname>Ishikawa</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Tonoki</surname><given-names>H</given-names></name><name><surname>Okano</surname><given-names>M</given-names></name><name><surname>Storch</surname><given-names>WB</given-names></name><name><surname>Moriuchi</surname><given-names>T</given-names></name><name><surname>Sakiyama</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name></person-group><article-title>Identification of an autoimmune enteropathy-related 75-kilodalton antigen</article-title><source>Gastroenterology</source><year>1999</year><volume>117</volume><fpage>823</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1016/S0016-5085(99)70340-9</pub-id></citation><citation citation-type="display-unstructured">Kobayashi I, Imamura K, Kubota M, Ishikawa S, Yamada M, Tonoki H, Okano M, Storch WB, Moriuchi T, Sakiyama Y, Kobayashi K (1999) Identification of an autoimmune enteropathy-related 75-kilodalton antigen. Gastroenterology 117:823&#x02013;830 <pub-id pub-id-type="pmid">10500064</pub-id></citation></ref><ref id="CR34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ronco</surname><given-names>PM</given-names></name></person-group><article-title>Paraneoplastic glomerulopathies: new insights into an old entity</article-title><source>Kidney Int</source><year>1999</year><volume>56</volume><fpage>355</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1755.1999.00548.x</pub-id></citation><citation citation-type="display-unstructured">Ronco PM (1999) Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int 56:355&#x02013;377 <pub-id pub-id-type="pmid">10411717</pub-id></citation></ref><ref id="CR35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seitz</surname><given-names>V</given-names></name><name><surname>Hummel</surname><given-names>M</given-names></name><name><surname>Marafioti</surname><given-names>T</given-names></name><name><surname>Anagnostopoulos</surname><given-names>I</given-names></name><name><surname>Assaf</surname><given-names>C</given-names></name><name><surname>Stein</surname><given-names>H</given-names></name></person-group><article-title>Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease</article-title><source>Blood</source><year>2000</year><volume>95</volume><fpage>3020</fpage><lpage>3024</lpage></citation><citation citation-type="display-unstructured">Seitz V, Hummel M, Marafioti T, Anagnostopoulos I, Assaf C, Stein H (2000) Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood 95:3020&#x02013;3024 <pub-id pub-id-type="pmid">10807764</pub-id></citation></ref><ref id="CR36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Audard</surname><given-names>V</given-names></name><name><surname>Larousserie</surname><given-names>F</given-names></name><name><surname>Grimbert</surname><given-names>P</given-names></name><name><surname>Abtahi</surname><given-names>M</given-names></name><name><surname>Sotto</surname><given-names>JJ</given-names></name><name><surname>Delmer</surname><given-names>A</given-names></name><name><surname>Boue</surname><given-names>F</given-names></name><name><surname>Nochy</surname><given-names>D</given-names></name><name><surname>Brousse</surname><given-names>N</given-names></name><name><surname>Delarue</surname><given-names>R</given-names></name><name><surname>Remy</surname><given-names>P</given-names></name><name><surname>Ronco</surname><given-names>P</given-names></name><name><surname>Sahali</surname><given-names>D</given-names></name><name><surname>Lang</surname><given-names>P</given-names></name><name><surname>Hermine</surname><given-names>O</given-names></name></person-group><article-title>Minimal change nephrotic syndrome and classical Hodgkin&#x02019;s lymphoma: report of 21 cases and review of the literature</article-title><source>Kidney Int</source><year>2006</year><volume>69</volume><fpage>2251</fpage><lpage>2260</lpage><pub-id pub-id-type="doi">10.1038/sj.ki.5000341</pub-id></citation><citation citation-type="display-unstructured">Audard V, Larousserie F, Grimbert P, Abtahi M, Sotto JJ, Delmer A, Boue F, Nochy D, Brousse N, Delarue R, Remy P, Ronco P, Sahali D, Lang P, Hermine O (2006) Minimal change nephrotic syndrome and classical Hodgkin&#x02019;s lymphoma: report of 21 cases and review of the literature. Kidney Int 69:2251&#x02013;2260 <pub-id pub-id-type="pmid">16672913</pub-id></citation></ref><ref id="CR37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>TH</given-names></name><name><surname>Morton</surname><given-names>CC</given-names></name><name><surname>Miller-Cassman</surname><given-names>R</given-names></name><name><surname>Balk</surname><given-names>SP</given-names></name><name><surname>Kadin</surname><given-names>ME</given-names></name></person-group><article-title>Hodgkin&#x02019;s disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone</article-title><source>N Engl J Med</source><year>1992</year><volume>326</volume><fpage>1115</fpage><lpage>1122</lpage></citation><citation citation-type="display-unstructured">Davis TH, Morton CC, Miller-Cassman R, Balk SP, Kadin ME (1992) Hodgkin&#x02019;s disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 326:1115&#x02013;1122 <pub-id pub-id-type="pmid">1532439</pub-id></citation></ref><ref id="CR38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karras</surname><given-names>A</given-names></name><name><surname>Montpreville</surname><given-names>V</given-names></name><name><surname>Fakhouri</surname><given-names>F</given-names></name><name><surname>Gr&#x000fc;nfeld</surname><given-names>JP</given-names></name><name><surname>Lesavre</surname><given-names>P</given-names></name><collab>Groupe d&#x02019;Etudes des N&#x000e9;phropathies Associ&#x000e9;es aux Thymomes</collab></person-group><article-title>Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature</article-title><source>Nephrol Dial Transplant</source><year>2005</year><volume>20</volume><fpage>1075</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfh615</pub-id></citation><citation citation-type="display-unstructured">Karras A, de Montpreville V, Fakhouri F, Gr&#x000fc;nfeld JP, Lesavre P, Groupe d&#x02019;Etudes des N&#x000e9;phropathies Associ&#x000e9;es aux Thymomes (2005) Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol Dial Transplant 20:1075&#x02013;1082 <pub-id pub-id-type="pmid">15788438</pub-id></citation></ref><ref id="CR39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>L</given-names></name></person-group><article-title>Changing European CKD trends: a call to action</article-title><source>J Ren Care</source><year>2007</year><volume>33</volume><fpage>148</fpage><lpage>152</lpage></citation><citation citation-type="display-unstructured">Bennett L (2007) Changing European CKD trends: a call to action. J Ren Care 33:148&#x02013;152 <pub-id pub-id-type="pmid">18298031</pub-id></citation></ref><ref id="CR40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nivet</surname><given-names>H</given-names></name><name><surname>Maingourd</surname><given-names>C</given-names></name><name><surname>Mignon</surname><given-names>F</given-names></name></person-group><article-title>Demography of nephrologists in France in 2002</article-title><source>N&#x000e9;phrologie</source><year>2003</year><volume>24</volume><fpage>431</fpage><lpage>436</lpage></citation><citation citation-type="display-unstructured">Nivet H, Maingourd C, Mignon F (2003) Demography of nephrologists in France in 2002. N&#x000e9;phrologie 24:431&#x02013;436 <pub-id pub-id-type="pmid">14737975</pub-id></citation></ref></ref-list></back></article>